André Tchernof

No ORCID on file · 6 papers in corpus
observational 2024
BMC endocrine disorders ·doi:10.1186/s12902-024-01567-8

BACKGROUND: A better understanding of adipose tissue (AT) dysfunction, which includes morphological and functional changes such as adipocyte hypertrophy as well as impaired adipogenesis, lipid storage/mobilization, endocrine and inflammator…

observational 2022
Adipocyte ·doi:10.1080/21623945.2022.2059902

Adipose tissue (AT) dysfunctions, such as adipocyte hypertrophy, macrophage infiltration and secretory adiposopathy (low plasma adiponectin/leptin, A/L, ratio), associate with metabolic disorders. However, no study has compared the relative…

observational 2016
PloS one ·doi:10.1371/journal.pone.0166138

CONTEXT: Lactoferrin (Lf) is an important protein found on mucosal surfaces, within neutrophils and various cells, and in biological fluids. It displays multiple functions, including iron-binding as well as antimicrobial, immunomodulatory a…

observational 2015
Journal of lipid research ·doi:10.1194/jlr.p058578

Occurrence of oxidative stress in white adipose tissues contributes to its dysfunction and the development of obesity-related metabolic complications. Coenzyme Q10 (CoQ10) is the single lipophilic antioxidant synthesized in humans and is es…

other 2014
Adipocyte ·doi:10.4161/adip.29385

Subcutaneous adipose tissue expansion through adipogenesis is increasingly recognized as a major determinant of body fat distribution and obesity-related cardiometabolic alterations. Our objective was to assess whether adipogenic rates of c…

observational 2011
Diabetes ·doi:10.2337/db10-1039

OBJECTIVE: We assessed whether subcutaneous and omental adipocyte hypertrophy are related to metabolic alterations independent of body composition and fat distribution in women. RESEARCH DESIGN AND METHODS: Mean adipocyte diameter of paire…